Valsartan Tablet, Film Coated
FDA Label NDC 70771-1885

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Valsartan (NDC 70771-1885). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

Valsartan tablets USP, 40 mg

NDC 70771-1882-3

Bottle of 30 Scored Tablets

Rx only

40 mg (A69225f3 D9ea 4ed4 B7ab 225147cad486 01)

Valsartan tablets USP, 80 mg

NDC 70771-1883-9

Bottle of 90 tablets

Rx only

80 mg (A69225f3 D9ea 4ed4 B7ab 225147cad486 02)

Valsartan tablets USP, 160 mg

NDC 70771-1884-9

Bottle of 90 tablets

Rx only

160 mg (A69225f3 D9ea 4ed4 B7ab 225147cad486 03)

Valsartan tablets USP, 320 mg

NDC 70771-1885-9

Bottle of 90 tablets

Rx only

320 mg (A69225f3 D9ea 4ed4 B7ab 225147cad486 04)

* Please review the disclaimer below.